Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Regulatory Material −

Regenera to be late to file 2025 results

Regenera Insights Misses Filing Deadline as Stock Slumps to Penny-Stock Lows

By The Northwire Desk — AI Analysis May 01, 2026 · 17:40 RGEN · 0.015 Regenera Insights Inc
Executive Summary
  • Regenera Insights Inc. announced on May 1, 2026, that it failed to file its audited annual financial statements, MD&A, and related certifications for the fiscal year ended December 31, 2025, by the regulatory deadline.
  • The company is applying for a management cease trade order (MCTO) under National Policy 12-203 to allow continued trading of common shares by non-insiders while filings are completed.
  • Management expects all delayed financial statements and restated quarterly reports (for Q2 and Q3 2025) to be filed no later than May 8, 2026.
  • The company committed to issuing biweekly default status reports if required by the policy to update stakeholders on remedial actions.
  • Management confirmed the company is not subject to insolvency proceedings and has no other undisclosed material information at this time.
Material Impact
  • Regulatory Risk: The failure to file annual results is a significant compliance breach for a public entity. While an MCTO application mitigates immediate trading halts, it signals internal control weaknesses or resource constraints within the finance team.
  • Credibility Concern: The requirement to restate financial statements for Q2 and Q3 2025 suggests previous filings may have contained errors or required adjustments, undermining investor confidence in historical data accuracy.
  • Market Sentiment: This news is unexpected and negative. It confirms the downward trend observed in the stock price leading up to May 2026 (dropping from $0.04 to $0.02).
  • Liquidity Implications: While trading remains open via MCTO, institutional investors often have mandates prohibiting investment in companies with filing defaults, potentially restricting capital access.
RGEN · Price
Company Overview
  • Company: Regenera Insights Inc. is a public entity trading under the ticker RGEN (inferred from URL data).
  • Flagship Project: No specific projects, assets, or operational details were provided in the news release or historical data. The company appears to be in a reporting phase rather than an active development phase based on the focus on financial filings.
  • Development Status: Currently facing administrative and regulatory hurdles regarding financial transparency for fiscal year 2025.
Read the original news release →